Alector Inc., a late-stage clinical biotechnology company focused on therapies for neurodegeneration, will present at the H.C. Wainwright 27th Annual Global Investment Conference in New York on Tuesday, September 9, 2025, at 1:30 p.m. ET. A webcast of the presentation will be available on Alector's website.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alector Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9519426-en) on August 28, 2025, and is solely responsible for the information contained therein.